Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report

Background Diffuse alveolar bleeding is a potentially life-threatening condition that can be induced by several drugs. Whereas fatal cases have been reported in patients treated for other indications, no report have so far been published in a patient with multiple sclerosis treated with alemtuzumab.